Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

420 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and Efficacy of Checkpoint Inhibition in Patients With Melanoma and Preexisting Autoimmune Disease : A Cohort Study.
van der Kooij MK, Suijkerbuijk KPM, Aarts MJB, van den Berkmortel FWPJ, Blank CU, Boers-Sonderen MJ, van Breeschoten J, van den Eertwegh AJM, de Groot JWB, Haanen JBAG, Hospers GAP, Piersma D, van Rijn RS, Ten Tije AJ, van der Veldt AAM, Vreugdenhil G, van Zeijl MCT, Wouters MWJM, Dekkers OM, Kapiteijn E. van der Kooij MK, et al. Among authors: dekkers om. Ann Intern Med. 2021 May;174(5):641-648. doi: 10.7326/M20-3419. Epub 2021 Feb 16. Ann Intern Med. 2021. PMID: 33587686
Therapy of endocrine disease: response and toxicity of small-molecule tyrosine kinase inhibitors in patients with thyroid carcinoma: a systematic review and meta-analysis.
Klein Hesselink EN, Steenvoorden D, Kapiteijn E, Corssmit EP, van der Horst-Schrivers AN, Lefrandt JD, Links TP, Dekkers OM. Klein Hesselink EN, et al. Among authors: dekkers om. Eur J Endocrinol. 2015 May;172(5):R215-25. doi: 10.1530/EJE-14-0788. Epub 2015 Jan 8. Eur J Endocrinol. 2015. PMID: 25572389 Review.
Sex-Based Differences in Treatment with Immune Checkpoint Inhibition and Targeted Therapy for Advanced Melanoma: A Nationwide Cohort Study.
van der Kooij MK, Dekkers OM, Aarts MJB, van den Berkmortel FWPJ, Boers-Sonderen MJ, de Groot JWB, Hospers GAP, Piersma D, van Rijn RS, Suijkerbuijk KPM, Westgeest HM, van der Veldt AAM, Vreugdenhil G, Wilgenhof S, Wouters MWJM, Haanen JBAG, van den Eertwegh AJM, Kapiteijn E. van der Kooij MK, et al. Among authors: dekkers om. Cancers (Basel). 2021 Sep 16;13(18):4639. doi: 10.3390/cancers13184639. Cancers (Basel). 2021. PMID: 34572865 Free PMC article.
Endocrine-related adverse conditions in patients receiving immune checkpoint inhibition: an ESE clinical practice guideline.
Husebye ES, Castinetti F, Criseno S, Curigliano G, Decallonne B, Fleseriu M, Higham CE, Lupi I, Paschou SA, Toth M, van der Kooij M, Dekkers OM. Husebye ES, et al. Among authors: dekkers om. Eur J Endocrinol. 2022 Oct 25;187(6):G1-G21. doi: 10.1530/EJE-22-0689. Print 2022 Dec 1. Eur J Endocrinol. 2022. PMID: 36149449 Free PMC article.
Distinguishing case series from cohort studies.
Dekkers OM, Egger M, Altman DG, Vandenbroucke JP. Dekkers OM, et al. Ann Intern Med. 2012 Jan 3;156(1 Pt 1):37-40. doi: 10.7326/0003-4819-156-1-201201030-00006. Ann Intern Med. 2012. PMID: 22213493
MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patients.
de Laat JM, van der Luijt RB, Pieterman CR, Oostveen MP, Hermus AR, Dekkers OM, de Herder WW, van der Horst-Schrivers AN, Drent ML, Bisschop PH, Havekes B, Vriens MR, Valk GD. de Laat JM, et al. Among authors: dekkers om. BMC Med. 2016 Nov 15;14(1):182. doi: 10.1186/s12916-016-0708-1. BMC Med. 2016. PMID: 27842554 Free PMC article.
420 results